Alitretinoin (9-cis retinoic acid) is effective against Pityriasis rubra pilaris: A retrospective clinical study

Acta Dermato-Venereologica

Volumn 95, Issue 3, 2015, Pages 329-331

  Amann, Philipp M ^a,b   Susic, Marijan ^a   Glüder, Franziska ^a   Berger, Hans ^a   Krapf, Wolfgang ^a   Löffler, Harald ^a,c  

^a SLK Clinic Heilbronn GmbH   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Alitretinoin; Pityriasis rubra pilaris; Psoriasis; Retinoic acid; Retinoids; Vitamin A

Indexed keywords

ALITRETINOIN; CREATINE KINASE; ETRETIN; KERATOLYTIC AGENT; RETINOIC ACID;

ABNORMAL LABORATORY RESULT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTRANSAMINASEMIA; MALE; MEDICAL PHOTOGRAPHY; MIDDLE AGED; OBSERVATIONAL STUDY; PITYRIASIS RUBRA PILARIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SYSTEMIC THERAPY; VERY ELDERLY; REMISSION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KERATOLYTIC AGENTS; MALE; MIDDLE AGED; PITYRIASIS RUBRA PILARIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRETINOIN;

EID: 84922823049     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1928     Document Type: Article

References (15)

1. Amann PM, Eichmuller SB, Schmidt J, Bazhin AV. Regulation of gene expression by retinoids. Curr Med Chem 2011; 18: 1405–1412.
2. Vahlquist A. Retinoids and the skin: from vitamin A in human epidermis to the pharmacology of oral retinoids in dermatology. In: Vahlquist A, Duvic M, editors. Retinoids and carotenoids in dermatology. London: Taylor & Francis, 2007: p. 55–68.
3. Ruzicka T, Lynde CW, Jemec GB, Diepgen T, Berth-Jones J, Coenraads PJ, et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 2008; 158: 808–817.
4. Letule V, Herzinger T, Ruzicka T, Molin S. Treatment of Darier disease with oral alitretinoin. Clin Exp Dermatol 2013; 38: 523–525.
5. Irla N, Navarini AA, Yawalkar N. Alitretinoin abrogates innate inflammation in palmoplantar pustular psoriasis. Br J Dermatol 2012; 167: 1170–1174.
6. Gånemo A, Sommerlund M, Vahlquist A. Oral alitretinoin in congenital ichthyosis: a pilot study shows variable effects and a risk of central hypothyroidism. Acta Derm Venereol 2012; 92: 256–257.
7. Klein A, Landthaler M, Karrer S. Pityriasis rubra pilaris: a review of diagnosis and treatment. Am J Clin Dermatol 2010; 11: 157–170.
8. Molin S, Ruzicka T. Treatment of refractory pityriasis rubra pilaris with oral alitretinoin: case report. Br J Dermatol 2010; 163: 221–223.
9. Pampin A, Gomez-de la Fuente E, Caro Gutierrez MD, Lopez-Estebaranz JL. Successful treatment of atypical adult pityriasis rubra pilaris with oral alitretinoin. J Am Acad Dermatol 2013; 69: e105–106.
10. Schmitt L, Inhoff O, Dippel E. Oral alitretinoin for the treatment of recalcitrant pityriasis rubra pilaris. Case Rep Dermatol 2011; 3: 85–88.
11. Xu J, Drew PD. 9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes. J Neuroimmunol 2006; 171: 135–144.
12. Meyer V, Goerge T, Luger TA, Beissert S. Successful treatment of palmoplantar hyperkeratotic psoriasis with a combination of etanercept and alitretinoin. J Clin Aesthet Dermatol 2011; 4: 45–46.
13. Wohlrab J, Kreft B. Treatment of pityriasis rubra pilaris with ustekinumab. Br J Dermatol 2010; 163: 655–656.
14. Ruiz Villaverde R, Sanchez Cano D. Successful treatment of type 1 pityriasis rubra pilaris with ustekinumab therapy. Eur J Dermatol 2010; 20: 630–631.
15. Petrof G, Almaani N, Archer CB, Griffiths WA, Smith CH. A systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNF-antagonists. J Eur Acad Dermatol Venereol 2013; 27: e131–135.